fda warning letter hims & hers compounded semaglutide september 2025 cancels plans to sell GLP-1 pill after backlash Hims & Hers falls 8%

Semaglutide added to basal insulin in type 2 diabetes (sustain 5): a randomized, controlled trial

Recent studies suggest that tirzepatide may also have direct effects on the blood vessels themselves, potentially through its dual action on GLP-1 and GIP receptors 4,5

However, the authors did not provide images of morphologically identifiable synapses at the ultrastructural level

[DOI] [PubMed] [Google Scholar] 747.Egecioglu E., Steensland P., Fredriksson I., Feltmann K., Engel J.A., Jerlhag E

By June, employers, health systems, and PBMs have something far more valuable than forecasts: six months of real-world claims experience